Marek Dráb
Impact in
- Cell Biology top 0.5%
- Caveolin-1 and cellular processes
- Microbiology top 5%
Papers in
-
- Metabolism, Diabetes, and Cancer 2
- RNA Interference and Gene Delivery 2
- Cell Biology 10
- Caveolin-1 and cellular processes 9
- Co-authors
- Friedrich C. Luft (5 shared papers)Teymuras V. Kurzchalia (3 shared papers)Carsten Lindschau (3 shared papers)Michael Kasper (4 shared papers)Hermann Haller (2 shared papers)Jan Menne (1 shared paper)Paul Verkade (1 shared paper)Marlies Elger (1 shared paper)
- Journals
- Scientific Reports (3 papers)Biochemical and Biophysical Research Communications (2 papers)Journal of Biological Chemistry (2 papers)Sensors and Actuators B Chemical (1 paper)Pharmaceutics (1 paper)
- Partner nations
- PolandGermanyUnited States
In The Last Decade
Marek Dráb
45 papers receiving 3.0k citations
Marek Dráb's Hit Papers
Peers
Comparison fields: 5 of 124
- Cell Biology 1.3k
- Microbiology 156
- Aging 43
- Molecular Biology 1.6k
- Physiology 431
Countries citing papers authored by Marek Dráb
This map shows the geographic impact of Marek Dráb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marek Dráb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marek Dráb more than expected).
Fields of papers citing papers by Marek Dráb
This network shows the impact of papers produced by Marek Dráb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marek Dráb. The network helps show where Marek Dráb may publish in the future.
Co-authors
The 25 scholars most cited alongside Marek Dráb, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Loss of Caveolae, Vascular Dysfunction, and Pulmonary Defects in Caveolin-1 Gene-Disrupted Mice Hit paper breakdown → | 2001 | 1330 |
| 2 | 2015 | 249 | |
| 3 | 1997 | 201 | |
| 4 | 2008 | 189 | |
| 5 | 1997 | 150 | |
| 6 | 2005 | 76 | |
| 7 | 2011 | 76 | |
| 8 | 1997 | 71 | |
| 9 | 2005 | 60 | |
| 10 | 2017 | 59 | |
| 11 | 1998 | 57 | |
| 12 | 2007 | 50 | |
| 13 | 1998 | 47 | |
| 14 | 2006 | 39 | |
| 15 | The role of hyperglycemia and hyperinsulinemia in the pathogenesis of diabetic angiopathy. | 1996 | 38 |
| 16 | 2021 | 34 | |
| 17 | 2019 | 32 | |
| 18 | 2015 | 31 | |
| 19 | 2009 | 28 | |
| 20 | 2016 | 27 |
About Marek Dráb
Marek Dráb is a scholar working on Molecular Biology, Cell Biology, Ecology, Biomedical Engineering and Cardiology and Cardiovascular Medicine, having authored 45 papers that have together received 3.1k indexed citations. Recurring topics across this work include Caveolin-1 and cellular processes (9 papers), Bacteriophages and microbial interactions (6 papers), Biosensors and Analytical Detection (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Atherosclerosis and Cardiovascular Diseases (3 papers), Metabolism, Diabetes, and Cancer (2 papers), Pregnancy and preeclampsia studies (2 papers) and RNA Interference and Gene Delivery (2 papers). The work is most often cited by research in Cell Biology (1.3k citations), Microbiology (156 citations), Aging (43 citations), Molecular Biology (1.6k citations) and Physiology (431 citations). Marek Dráb has collaborated with scholars based in Poland, Germany and United States. Frequent co-authors include Friedrich C. Luft, Teymuras V. Kurzchalia, Carsten Lindschau, Michael Kasper, Hermann Haller, Jan Menne, Paul Verkade, Marlies Elger, Fanny Mende and Andreas Schedl. Their work appears in journals such as Scientific Reports, Biochemical and Biophysical Research Communications, Journal of Biological Chemistry, Sensors and Actuators B Chemical and Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.